Introduction {#s1}
============

Infertility is a common problem, affecting 10-15% of all couples, and in around half of the cases the cause is related to males \[[@CIT0012]\]. The cells which give rise to the male gametes (spermatozoa) are the spermatogonial stem cells (SSCs), which originate from the primordial germ cells (PGCs) present in the fetus \[[@CIT0039]\]. Due to obvious ethical reasons these cells cannot be studied *in vivo* and little is known about the early developmental phase, due to technical difficulties *in vitro*. Therefore, providing an alternative source of germ cells would be of interest for studying the early mechanisms of germ cell differentiation and identifying potential causes of infertility.

Human embryonic stem cells (hESCs) are promising candidates for regenerative medicine due to their pluripotency and capability to self-renew \[[@CIT0006]; [@CIT0041]\]. An important factor for hESC self-renewal and pluripotency is fibroblast growth factor 2 (FGF2) \[[@CIT0029]; [@CIT0035]\]. When deprived of FGF2, hESCs lose their pluripotency and differentiate spontaneously \[[@CIT0017]; [@CIT0028]; [@CIT0029]\]. Although hESC represent very early stages of differentiation, different hESC lines have been shown to vary in their characteristics and potential to differentiate. Most hESC lines have the tendency to differentiate towards either one of the three germ cell layers \[[@CIT0001]; [@CIT0030]\]. This difference between hESC lines has furthermore been reported to be laboratory specific \[[@CIT0032]\].

Regarding differentiation potential of these cell lines, hESCs have been shown to differentiate spontaneously to early germ cells when cultured as embryoid bodies \[[@CIT0010]\] and also in adherent monolayer with mouse embryonic fibroblasts (mEFs) \[[@CIT0007]; [@CIT0028]; [@CIT0044]\]. In terms of the germ lineage, it has been shown that both mouse embryonic stem cells (mESCs) and hESCs are capable to differentiate to male and female germ cells *in vitro* but with low efficiency \[[@CIT0010]; [@CIT0021]; [@CIT0033]; [@CIT0042]\]. Many factors have been suggested to play a role in germ cell development. One of them is all-trans retinoic acid (ATRA), which is generated by a series of oxidative reactions from the dietary vitamin A. ATRA is known to play an important role in spermatogenesis and is believed to be a growth activator of mouse PGCs *in vitro* \[[@CIT0005]; [@CIT0025]\]. Previous studies have used various concentrations of ATRA for stimulating germ cell differentiation from both mESCs and hESCs \[[@CIT0014]; [@CIT0015]; [@CIT0034]\].

In order to optimize a general protocol for early germ cell differentiation for hESCs we asked whether human foreskin fibroblasts (hFFs), which have been shown to be supportive for hESC cultures \[[@CIT0019]; [@CIT0020]\] were able to support spontaneous differentiation of different hESCs to germ cell linage when no additional FGF2 was added to the culture media. Additionally, we investigated if hESC lines can be further differentiated in general into germ cells when stimulated with ATRA.

Results {#s2}
=======

Three different hESC lines derived in two different laboratories were used to evaluate whether hFFs could support germ cell differentiation in general during long term culture without supplementing the culture media with FGF2. These cells were also examined to determine whether they could be further stimulated with ATRA towards germ cell lineage and if the stimulation was dosage dependent.

Gene expression comparison of three undifferentiated hESC lines before and after spontaneous differentiation in adherent culture on hFFs {#s2a}
----------------------------------------------------------------------------------------------------------------------------------------

A panel of 96 genes was used to compare the gene signature for three undifferentiated hESC lines (LRB010, LRB017, and CLS1). Each cell line showed a unique signature of both stem cell related genes and genes linked to differentiation. However, to get an overview about a more general effect of the absence of exogenous FGF2, we compared the gene expression of 96 genes pooled for all three hESC lines (LRB010, LRB017, and CLS1) treated with FGF2 against untreated. Hereby, we revealed significant differences between six genes *eukaryotic elongation factor 1alpha1* (*EEF1A1), fms-related tyrosine kinase 1* (*FLT1), paired box-6 (PAX6), nuclear receptor subfamily 6, group A, member 1 (NR6A1), POU class 5 homeobox 1 (POU5F1),* and *pancreas specific transcription factor, 1A (PTF1A)* ([Fig. 1](#F1){ref-type="fig"}). All six genes were up-regulated by the absence of exogenous FGF2, whereas the other 90 genes showed no significant difference between treated and untreated cultures ([Supplementary Table 1](#S1){ref-type="supplementary-material"}).

![Effect of long-term hESC culture without exogenous FGF2. The pooled analysis revealed a significant up-regulation of six genes related to endothelial (*FLT-1* and *PTF1A-p48*), neuronal cells (*PAX6* and *NR6A1*), as well as pluripotency (*POU5F1*) and cancer related genes when up-regulated (*EEF1A*1). Relative quantity was calculated by ddCt method for each sample, from the mean of four replicates. Error bars: SEM: standard deviation of the mean, Significance: \**P* \< 0.05, \*\**P* \< 0.01](AAN-58-330-g001){#F1}

Effect of ATRA stimulation on DDX4, DAZL, POU5F1, and NANOG gene expression in hESCs cultured in the absence of FGF2 {#s2b}
--------------------------------------------------------------------------------------------------------------------

Expression of germ cell marker (*DDX4* and *DAZL*) as well as markers for pluripotency (*POU5F1* and *NANOG*) was evaluated with quantitative polymerase chain reaction (Q-PCR) for three hESC lines (LRB010, LRB017, and CLS1) after differentiating for 7 days with ATRA stimulation, but without exogenous stimulation of FGF2 for 12 weeks. This revealed no significant elevated gene expression of any of the tested genes, when all cell lines were analyzed together.

Whereas, the analysis of these genes showed a quite homogenous expression pattern for *POU5F1* ([Fig. 2](#F2){ref-type="fig"}A), *NANOG* and *DAZL* ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"}) for each cell line ([Fig. 2](#F2){ref-type="fig"}a-c), the expression of *DDX4* instead varies between the different cell lines ([Fig. 2](#F2){ref-type="fig"}B). While CLS1 and LRB010 showed no increased *DDX4* expression levels after stimulation with different ATRA concentrations ([Fig. 2](#F2){ref-type="fig"}d and f), when compared to the starting cell population (cultured for 12 weeks without exogenous FGF2), LRB017 showed a strong response (highest after stimulation with 500 ng) after stimulation for 7 days when compared to the situation at day 0 ([Fig. 2](#F2){ref-type="fig"}e). Normal hFFs were used as negative control for all genes. hFFs showed a significant lower expression of all analyzed genes when compared to the hESCs at the start of the culture (day 0; [Fig. 2](#F2){ref-type="fig"}).

![Stem (*POU5F1*, A) and germ cell (*DDX4*, B) markers pooled (A and B) and single evaluation (a-f) in three hESC lines after stimulation with ATRA for 7 days *in vitro*. No up- or down-regulation could be observed by Q-PCR gene expression analysis after supplementation with ATRA when all cell lines were pooled (A and B). Gene expression of germ cell markers in LRB017 showed a positive response to the supplementation with ATRA when compared to day 0. Day 0 is control hESCs that have been spontaneously differentiated on hFFs for 12 weeks and showed a significant higher expression of *POU5F1* and *DDX4* genes compared to hFF alone. Relative quantity was calculated by ddCt method for each sample, from the mean of three replicates. Error bars: SD: standard deviation, Significance: \*\*\**P* \< 0.001](AAN-58-330-g002){#F2}

Focusing the effect of ATRA stimulation on DDX4 expression in LRB017, we further investigated protein levels of DDX4, POU5F1, and PAX6 in LRB017 after stimulation with different concentrations of ATRA ([Fig. 3](#F3){ref-type="fig"}). While the gene expression analysis revealed in the strongest up-regulation with 500 ng/ml, the strongest protein expression was observed after 7 days stimulation with 100 ng/ml ATRA *in vitro* ([Fig. 3](#F3){ref-type="fig"}). After 14 days of ATRA stimulation, the highest protein expression was observed after stimulation with 500 ng/ml ([Fig. 3](#F3){ref-type="fig"}). Evaluating POU5F1 expression on protein level, POU5F1 revealed a strong expression when stimulated for 7 day or 14 days with ATRA ([Fig. 3](#F3){ref-type="fig"}). However, PAX6 expression was not observed after ATRA stimulation for 7 or 14 days (data not shown).

![Western blot analysis of DDX4 and POU5F1 in LRB017 after stimulation with ATRA for 7 and 14 days. ATRA is all-trans retinoic acid dissolved in DMSO. Positive control for DDX4 is human adult testis and for POU5F1 is undifferentiated hESCs (LRB017). All markers analyzed DDX4, POU5F1, and GAPDH showed bands of expected size (75kDa, 43kDa, and 35kDa, respectively).](AAN-58-330-g003){#F3}

DDX4 expression in undifferentiated hESCs {#s2c}
-----------------------------------------

In addition to the three cell lines used in the experiments mentioned above, we detected *DDX4* RNA in 8 additional undifferentiated hESC lines and 3 human induced pluripotent stem cell (hiPSC) lines when defining the status of *DDX4* in those stem cell lines. Our experiment showed expression of *DDX4* RNA in all undifferentiated cell lines analyzed (in total 14 different undifferentiated pluripotent cell lines), albeit at varying levels ([Fig. 4](#F4){ref-type="fig"}). DDX4 protein expression was not detected when analyzing four undifferentiated hESC lines (H9, HS207, HS360, and HS401) by immunocytochemical analysis ([Fig. 5](#F5){ref-type="fig"}).

![*DDX4* expression at RNA level in 8 undifferentiated hESC lines and 3 hiPSC lines established in 5 different laboratories. *DDX4* expression was detected at RNA level in all cell lines analyzed. Relative quantity was calculated by ddCt method for each sample from mean of three replicates.](AAN-58-330-g004){#F4}

![Immunocytochemical evaluation of DDX4 expression in hESC lines. No specific protein expression of DDX4 could be observed in any of the evaluated stem cells lines (black arrows, H9 (A), HS207 (B), HS360 (C) and HS401 (D)), whereas positive protein expression of DDX4 (white arrow heads) could be observed in male germ cells in cross-sections of a human testicular biopsy (E). Negative controls for the primary antibody for all samples are shown as small Figures (A-E). Scale bars: 50µm.](AAN-58-330-g005){#F5}

Discussion {#s3}
==========

Spontaneous differentiation of hESCs towards early germ cell lineage on mEFs has previously been shown \[[@CIT0007]; [@CIT0028]; [@CIT0043]\]. In order to answer the question if hESCs in general could be spontaneously differentiated towards the germ cell lineage on hFFs we cultured three hESCs in absence of exogenous FGF2 and combined the results of all three cell lines, in order to reduce cell line specific effects which are well-known for hESC lines. The expression analysis showed a significant up-regulation of 6 out of 96 genes when three hESC lines (LRB010, LRB017, and CLS1) were cultured without supplementation of FGF2 for 12 weeks and analyzed together. A significant up-regulation was observed in *EEF1A1*, which is ubiquitously expressed in mammalian cells and takes part in various important cellular mechanisms (e.g., cytoskeletal remodeling) as well as control mechanisms of cell cycle, growth, and death \[[@CIT0023]; [@CIT0024]; [@CIT0036]\] and the modulation of cell signaling \[[@CIT0047]\]. Recently, the over expression of *EEF1A1* has been connected to the formation of cancer (e.g., prostate cancer) and cell proliferation activities \[[@CIT0036]; [@CIT0037]\]. When focusing on pluripotent markers, known to be expressed by stem as well as pluripotent cancer cells, significant up-regulation of *POU5F1* (also known as *OCT4*) and *NR6A1* (also known as *GCNF*) has been observed. *NR6A1* is known to repress *POU5F1* \[[@CIT0009]\] . Therefore the up-regulation of these genes might be the result of the interaction between both genes. Additionally, *NR6A1* has been mentioned to be involved in the transition from primitive neuronal stem cells (pNSC) to definitive neural stem cells (dNSC) \[[@CIT0004]\]. Consistent with this finding Greber et al. \[2011\] demonstrated very recently, that FGF2 inhibits neuronal induction of hESCs when cultured on the extracellular matrix Matrigel. Focusing on genes expressed in neuronal cells, our combined analysis of all three different hESCs showed a significant increase of *NR6A1* and *PAX6* supporting the published data in a more general way. Another marker, up-regulated after 12 weeks of culture without FGF2 was *FLT-1* (also known as *VEGFR-1*), which is known to play a role in tumor growth in different organs (e.g., brain, lung, prostate) \[[@CIT0016]; [@CIT0038]\], and is expressed in the vascular endothelium. Consistent with this we found *PTF1A* up-regulated. *PTF1A* is a basic helix-loop-helix (bHLH) transcription factor which is activated by vascular endothelium \[[@CIT0026]; [@CIT0027]\]. In summary, the combined analysis of all three hESCs revealed that culturing without exogenous FGF2 initiates the up-regulation of genes expressed in neuronal as well as endothelial cells, which is consistent with previous studies using single cell lines. However, a spontaneous up-regulation of markers crucial for germ cell differentiation as well as a down-regulation of pluripotency markers could not be demonstrated. Therefore, the lack of exogenous FGF2 does not ensure the absence of the FGF pathway.

Additionally to spontaneous differentiation of hESCs without exogenous FGF2, we investigated the general effect of different concentrations of ATRA on the direction towards germ cell differentiation. ATRA is the active form of vitamin A and has been shown to be essential for spermatogenesis \[[@CIT0040]; [@CIT0046]\]. Various concentrations of ATRA have been used in previously published studies for inducing germ cell differentiation from ESCs but an optimal concentration has not yet been published \[[@CIT0003]; [@CIT0013]; [@CIT0015]; [@CIT0031]\]. When analyzing all three cell lines together after culture for 7 days with different concentrations of ATRA, no overall significant up-regulation of the germ cell specific markers *DDX4* or *DAZL* could be shown for all 3 cell lines. In addition, no significant effect of down-regulation of the pluripotent markers *POU5F1* and *NANOG* could be observed. However, it has been shown in previous studies that hESC gene profiles differ even if they have common features. To show this effect on the reported germ cell specific marker *DDX4*, we checked additionally to our three hESC lines, eight hESC, as well as three hiPSC lines for their 'natural' expression of *DDX4*. As shown by other studies \[[@CIT0003]; [@CIT0022]; [@CIT0043]; [@CIT0045]\] and as expected, all cell lines showed an expression of *DDX4* on RNA level, but not on protein level when analyzed with immunocytochemistry (ICC). Therefore, we checked our three cell lines on a single cell line basis for the expression of DDX4 on RNA as well as protein after stimulation with ATRA. By this analysis we could demonstrate that only one cell line (LRB017) was able to show augmented DDX4 expression of RNA as well as protein after stimulation with ATRA for 7 and 14 days. DDX4 shows the highest expression after 7 day stimuli with 100 ng/ml ATRA on protein level while on RNA level the highest *DDX4* expression is observed after stimuli with 500 ng/ml ATRA. However, when evaluating POU5F1 expression on protein level, we observed no difference between the different stimuli with ATRA or the unstimulated LRB017 sample. The difference observed between DDX4 expression of RNA and protein can be explained by post transcriptional regulation and/or variation in mRNA and protein turnover rates \[[@CIT0011]; [@CIT0018]\]. This result demonstrates that hESCs have different tendencies to differentiate into different cell types and that choosing the 'optimal' hESC line is crucial for differentiation into specific cell types.

In summary, our study showed for the first time by analyzing hESCs in a combined way that culturing these cell lines on hFFs without exogenous supplementation of FGF2 results in a significant up-regulation of genes specific for endothelial as well as neuronal cells, but not for genes related to germ cell differentiation. We could also demonstrate that differentiation towards the germ lineage by stimulation with ATRA is cell line dependent and that *DDX4* is already expressed on RNA level in different levels in hESCs as well as hiPSCs.

Materials and Methods {#s4}
=====================

Ethics {#s4a}
------

All issues concerning the experimental setups and evaluation techniques have been approved by the local Scientific Ethical Committee, Region Midtjylland, Denmark and the Ethics Board of Karolinska Institutet, Stockholm, Sweden.

Stem cell culture {#s4b}
-----------------

All hESC lines used in this study were fully characterized and showed teratoma formation *in vivo*. The three hESC lines used for spontaneous differentiation and ATRA stimulation were: LRB017 (46,XY) and LRB010 (46,XY) both derived at the University Hospital in Copenhagen, Denmark, and CLS1 (46,XY) derived at Ciconia Private Hospital, Højbjerg, Denmark. All three cell lines had been derived using immunosurgery. The eight hESC lines used for detection of the reported germ cell specific marker DDX4 were: HS181 (46,XX), HS207 (46,XX), HS346 (46,XX), HS360 (46,XY), HS401 (46,XY) (all derived after isolating the inner cell mass mechanically at Karolinska Institutet, Karolinska University Hospital Huddinge, Sweden), H9 (46,XX, derived using immunosurgery at University of Wisconsin, USA), CLS2 (46,XY, derived using immunosurgery at Ciconia Private Hospital, Højbjerg, Denmark), and LRB003 (46,XY, derived using immunosurgery at the University Hospital in Copenhagen, Denmark). The three hiPSC lines used for detection of *DDX4* were reprogrammed by transfecting hFFs using a lentiviral system. CHiPSW and CHiPS22b were transfected with POU5F1, SOX2, LIN28, and NANOG while CHiPSA was transfected with NANOG, POU5F1, SOX2, KLF4, and MYC (University of Geneva, Geneva, Switzerland \[[@CIT0008]\]. The undifferentiated stem cell lines were cultured in two different laboratories on inactivated (irradiation 40 Gy) hFFs (CRL-2429; ATCC, Manassas, VA, USA) at 37°C in 5% CO~2~. Culture media used for the undifferentiated hESCs consisted of Knockout Dulbeccós Modified Eaglés medium (P/N 10829018, Invitrogen, Paisley, UK) supplemented with 20% Knockout serum replacement (P/N 10828028, Invitrogen), 0.5% penicillin-streptomycin (P/N 15140122, Invitrogen), 2mM L-Glutamine (P/N 25030024, Invitrogen), 1% non-essential amino acids (P/N 11140035, Invitrogen) and 0.5mM 2-mercaptoethanol (P/N M3148-25ml, Sigma Aldrich, Stockholm, Sweden). The media used for culturing undifferentiated stem cells was supplemented with either 4ng/ml (CLS1, CLS2, LRB010, LRB017, LRB003) or 8ng/ml FGF2 (the remaining cell lines) (P/N PHG-0021, Biosource, Camarillo, CA, USA). Undifferentiated stem cells were passaged enzymatically using either trypsin (TRYPSIN 0.05%, EDTA, P/N 25300062, Invitrogen) every 9-14 d (CLS1, CLS2, LRB010, LRB017, LRB003) or TrypLE select (P/N 12563011, Invitrogen) every 5-7 d (the remaining cell lines). Under these culture conditions all the hESC lines showed typical morphology of undifferentiated hESCs and expressed the six consensus markers for undifferentiated hESCs (*NANOG*, *POU5F1*, *GDF3*, *DNMT3B*, *GABRB3,* and *TDGF1*) \[[@CIT0002]\].

Differentiation of hESCs {#s4c}
------------------------

To induce spontaneous differentiation the CLS1, LRB017, and LRB010 hESC lines were cultured in an adherent culture on hFFs for 12 w without supplementing the culture media with FGF2. Cells were passaged every 9-14 d during the 12 w. After the 12 w of spontaneous differentiation, the cells were stimulated with different concentrations of ATRA dissolved in dimethyl sulfoxide ((DMSO) 20, 100, 500, 2500ng/ml, P/N R2625, Sigma-Aldrich) and cells were harvested for analysis at day 7 and 14 (Supplementary [Fig. 2](#F2){ref-type="fig"}). The media was changed every other day and the cells were not passaged during the stimulation time.

RNA isolation and cDNA amplification {#s4d}
------------------------------------

hESCs were harvested enzymatically using either trypsin (CLS1, CLS2, LRB010, LRB017, LRB003) or TrypLE select (remaining cell lines) and stored in RNAprotect Cell Reagent until time of RNA extraction. The RNA was isolated with RNeasy Mini Kit (P/N 74104, Qiagen, Hilden, Germany) according to manufactures protocol. The cells were homogenized by using QIAshredder (P/N 79654, Qiagen, Hilden, Germany). The RNA was treated with DNase 1 (P/N 048K6043, Sigma Aldrich). RNA concentration and quality was measured by Nanovue plus (GE Healthcare, Little Chalfont, UK). cDNA amplification was performed from 100 ng of RNA with High capacity cDNA RT Kit (P/N 4368814, Applied Biosystems (ABI), Carlsbad, CA, USA). The cDNA was pre-amplified with TaqMan PreAmplification Pool for human stem cell pluripotency array according to manufactureŕs protocol (P/N 4405625, ABI) before loading on TaqMan low density array cards (TLDA, P/N 438544, ABI).

Gene expression analysis {#s4e}
------------------------

TaqMan low density array cards (TLDA, P/N438544, ABI), designed by the International Stem Cell Initiative \[[@CIT0002]\], were used for comparative analysis of CLS1, LRB017, and LRB010 in undifferentiated state as well as after spontaneous differentiation for 12 w on hFFs. The analysis was done according to manufactures protocol. Briefly, the TLDA cards are based on TaqMan chemistry where gene expression of a panel of 96 genes was analysed in one run. The TLDA cards are pre-loaded with 96 TaqMan gene expression assays of importance for hESC pluripotency, self-renewal, and differentiation, together with six endogenous controls assigned for normalization. Mean of endogenous controls *18S*, *ACTB,* and *GAPDH* was used for normalization. Gene expression was calculated by taking mean of the quadruplicates of each sample, then normalized to mean of *18S*, *ACTB,* and *GAPDH* of the same sample (dCt). Undifferentiated CLS1 was used as calibrator (ddCT) and gene expression was finally presented as relative quantity (fold change (2^−ddCT^)). Q-PCR was performed on 7500 Fast Real-time PCR System (ABI) for ATRA stimulated hESCs as well as the 11 additional lines analyzed for *DDX4* expression. TaqMan Gene expression Master Mix (P/N 4369510, ABI) was used for TaqMan Gene expression assays from ABI: *DDX4* (*VASA*, Assay ID Hs00251859_m1), *DAZL* (Assay ID Hs00154706_m1), and *18S* (Assay ID Hs99999901_s1) was used for normalization. SYBR Green PCR Master Mix (P/N 4309155, ABI) was used for analysis with SYBR Green primers: *NANOG* fw 3′-CAA AGG CAA ACA ACC CAC TT--5′ rev 3′-CTG GAT GTT CTG GGT CTG G0T--5′. *POU5F1* fw 3′-GAC AAC AAT GAA AAT CTT CAG GAG A--5′ rev 3′-TTC TGG CGC CGG TTA CAG AAC CA -- 5′. *GAPDH* fw 3′- GAA GGT GAA GGT CGG AGT CAA C--5′ rev 3′- CAG AGT TAA AAG CAG CCC TGG T-- 5′. Gene expression was calculated by taking mean of the triplicates ran for each sample, and then normalized to mean of *18S* or *GAPDH* (depending on chemistry used) of the same sample (dCt). Cells from Day 0 of ATRA differentiation was used as calibrator of each cell line (ddCT) and gene expression was finally presented as relative quantity (fold change (2^−ddCT^)).

Protein isolation and quantification {#s4f}
------------------------------------

The LRB017 hESCs were harvested enzymatically with trypsin and lysed in lysis buffer (P/N 9803, Cell Signalling Technology, Danvers, MA, USA) and supplemented with 1mM phenylmethanesulphonylfluoride (PMSF), 5mM sodium fluoride (NaF), and 15mM Complete Mini Protease Inhibitor (P/N 11836153001, Roche Diagnostics, Indianapolis, IN, USA). The samples were incubated on ice for 30 min followed by 10 min centrifugation at 20,000g at 4°C. The lysate was harvested and protein concentration measured by Bio-Rad protein assay (Bradford method, P/N 500-0006, Bio-Rad).

Western blot analysis {#s4g}
---------------------

14 µg of each protein lysate were mixed with sample buffer (62.5 mM Tris base, 2% sodium dodecyl sulphate (SDS) and 10% glycerol, pH 6.9), 0.5% dithiothreitol (DTT), and a small quantity of bromophenol blue. The samples were heated for 5 min at 95°C. The proteins were separated on Criterion TGX Precast gel, 4-15% (P/N 567-1084, Bio-Rad, Hercules, CA, USA) with 1 × running buffer (P/N SC-24949, Bio-Rad) for 1 h at 140V and then electro-transferred to a Amersham^TM^ Hybond-P membrane (P/N RPN303F, GE Healthcare) at 130mA in transfer buffer (P/N 161-0734, Bio-Rad) for 1 h. The membranes were blocked with Amersham^TM^ ECL Prime Blocking Agent (50 g/L, P/N RPN418, GE Healthcare) in TBS (P/N SC-24951, Santa Cruz Biotechnology, Santa Cruz, CA, USA) with 0.1% Tween 20 for 1 h at room temperature (RT). The membranes were incubated with primary antibodies overnight and secondary antibodies for 2 h. Primary antibodies used for the western blotting were: goat polyclonal anti-GAPDH (diluted 1:200 (1 µg/ml), P/N SC-20357, Santa Cruz Biotechnology), rabbit polyclonal anti-DDX4 (diluted 1:1000 (1µg/ml), P/N ab13840, AbCam, Cambridge, UK), rabbit polyclonal anti-POU5F1 (diluted 1:400, P/N ab19857 Abcam) and rabbit polyclonal anti-PAX-6 (diluted 1:500 (0.4 µg/ml), P/N SC-11357, Santa Cruz Biotechnology). Secondary antibodies used for the western blotting were: horseradish peroxidase-conjugated (HRP) donkey anti-goat (diluted 1:5000 (0.08 µg/ml), P/N SC-2033, Santa Cruz Biotechnology) and HRP donkey anti-rabbit (diluted 1:5000 (0.08 µg/ml), P/N NA934V, GE Healthcare). The antibodies were all diluted in the blocking solution. As positive control for DDX4, POU5F1, and PAX-6, human protein lysates from adult testicular biopsies, hESCs (LRB017) and human fetal brain (P/N P1244035, BioChain, Hayward, CA, USA) were used. The membranes were developed with Amersham^TM^ ECL Prime Western Blotting Detection reagent (P/N RPN2232, GE Healthcare).

Immunocytochemistry (ICC) {#s4h}
-------------------------

hESCs (HS207, HS360, HS401, and H9) were harvested from culture media and fixed in 4% paraformaldehyde (PFA) overnight at 4°C and routinely embedded in paraffin (P/N P3808, Sigma Aldrich) after dehydration via gradually increasing ethanol concentration. Afterwards, samples were cut into 4 µm sections. 4% PFA fixed and paraffin embedded human testicular tissue was used as positive control for DDX4 detection of germ cells. The samples were rehydrated using xylene and gradually decreasing EtOH series. Briefly, the samples were blocked with 5% goat serum (P/N S-1000, Vector Laboratories, Peterborough, UK) in 0.1% bovine serum albumin (BSA) in phosphate buffered saline (PBS) for 20 min. Primary antibody, rabbit polyclonal anti-DDX4 (P/N ab13840, AbCam) was diluted (1:100 (10 µg/ml)) in 0.1% BSA in PBS and incubated overnight at 4°C. For the negative control for the primary antibody, samples were incubated with rabbit polyclonal IgGs (P/N ab27478, AbCam) with the same concentration of the primary antibody overnight at 4°C. The samples were washed three times for 5 min in PBS and afterwards directly incubated with the secondary antibody, biotinylated goat anti-rabbit IgG (ready to use, P/N ab64256, AbCam) for 1 h at 37°C. Samples were washed three times for 5 min in PBS and incubated with ABC reagent from Vectastain ABC-kit (P/N PK6100, Vector Laboratories) for 30 min at 37°C. The samples were washed three times and stained with DAB for 45 s at room temperature, washed again twice for 2 min in H~2~O, incubated for 7 s in haemalaun (P/N 1.09249.1000 Merck, Germany) and rinsed for 5 min in tap water. Samples were dehydrated in a gradually increasing EtOH series and xylene and mounted with Entellan® new (P/N 1.07961.0100 Merck) and analyzed under the microscope (Eclipse E800; Nikon; Japan) and pictures were taken with a 12.5 million-pixel cooled digital color camera system (Olympus DP70, Japan).

Statistical evaluation {#s4i}
----------------------

The gene expression levels were calculated as mean ± standard deviation (SD) or standard deviation of the mean (SEM) as stated in the figure legends. Student test (SigmaPlot 11.0; Systat Software Inc. CA, USA) was used to compare the difference between two experimental settings. A difference was considered statistically significant when the *p* value was ≤ 0.05.
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